11/24
08:15 am
pfsa
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
Medium
Report
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
11/20
01:16 am
pfsa
Profusa (NASDAQ:PFSA) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
High
Report
Profusa (NASDAQ:PFSA) is now covered by analysts at
Weiss Ratings. They set a "sell (e+)" rating on the stock.
11/19
06:42 pm
pfsa
Profusa Announces Third Quarter Business and Financial Highlights [Yahoo! Finance]
High
Report
Profusa Announces Third Quarter Business and Financial Highlights [Yahoo! Finance]
11/19
05:44 pm
pfsa
Profusa Announces Third Quarter Business and Financial Highlights
High
Report
Profusa Announces Third Quarter Business and Financial Highlights
10/30
07:30 am
pfsa
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
High
Report
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
10/28
08:30 am
pfsa
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Medium
Report
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
10/22
08:30 am
pfsa
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
Medium
Report
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
10/15
08:30 am
pfsa
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
Low
Report
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
10/7
08:15 am
pfsa
Profusa Invests Additional $1 Million in Digital Treasury Assets
High
Report
Profusa Invests Additional $1 Million in Digital Treasury Assets
10/1
09:23 am
pfsa
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base [Yahoo! Finance]
Medium
Report
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base [Yahoo! Finance]
10/1
08:30 am
pfsa
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
Medium
Report
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
9/11
09:39 am
pfsa
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform [Globe and Mail, The (Toronto, Canada)]
Low
Report
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform [Globe and Mail, The (Toronto, Canada)]
9/11
08:45 am
pfsa
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform
High
Report
Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen Platform
9/11
08:44 am
pfsa
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring [Yahoo! Finance]
Low
Report
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring [Yahoo! Finance]
9/11
08:30 am
pfsa
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
High
Report
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring